
Brain Atlas Improves Alzheimer’s Diagnostics
VIDEO + ARTICLE: Diagnostic technology is a powerful weapon in the fight against dementia. Find out how a new map of the ageing brain will

VIDEO + ARTICLE: Diagnostic technology is a powerful weapon in the fight against dementia. Find out how a new map of the ageing brain will

A startling new link shows Alzheimer’s in transplant patients is significantly lower, in fact almost absent, when compared to national data from the general population.

Lymphatic systems serve many tasks, including the draining of waste proteins. A unexpected new discovery found it reaches brain cells. Can it be boosted to

VIDEO + ARTICLE: A new epilepsy drug could be used to treat Alzheimer’s patients. Find out about this new experimental approach.

MEDICATION TRIALS: Although Astra Zeneca’s AZD05030 disappointed cancer researchers, it surprisingly blocked the damage caused by Alzheimer’s plaque. Learn about the speed with which this

VIDEO + ARTICLE: For 25 years, researchers tried curing Alzheimer’s by clearing amyloid plaque. While plaque is a problem, is it merely Alzheimer’s cargo, while

VIDEO: “For the first time I think we have a chance to really change the course of Alzheimer’s disease,” says Dr. Reisa Sperling. She’s leading

VIDEO & ARTICLE: CNBC’s Meg Tirrell reports on Biogen’s experimental drug for Alzheimer’s and how the company appears to have exceeded expectations.

VIDEO + ARTICLE: Earth’s gravity causes Alzheimer’s fibers to settle in the lab, before they can tangle. This is a big block in the search

VIDEO + ARTICLE: The Accelerating Medicines Partnership (AMP) is a bold new venture among the National Institutes of Health (NIH), 10 biopharmaceutical companies, and several

Could a nasal spray help memory loss? A new study using Aptar’s delivery system shows insulin reaching key brain regions, offering new hope for treating Alzheimer’s and mild cognitive impairment.

VIDEO + ARTICLE: A promising new oral therapy for Alzheimer’s is now recruiting participants across the USA and Australia, offering fresh hope to families affected by this devastating condition.

Leqembi, the first Alzheimer’s-modifying drug, is a giant step forward—but how many people are getting it, and what does it really cost the average American? We dig into the numbers, the barriers, and the path forward.

It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.


